Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort.

J. Ferlay, M. Colombet, I. Soerjomataram, T. Dyba, G. Randi, M. Bettio, A. Gavin, O. Visser, F. Bray, Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. European Journal of Cancer. ,vol. 103, pp. 356- 387 ,(2018) , 10.1016/J.EJCA.2018.07.005

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal, None, Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA: A Cancer Journal for Clinicians. ,vol. 68, pp. 394- 424 ,(2018) , 10.3322/CAAC.21492

Nicholas C. Turner, Dennis J. Slamon, Jungsil Ro, Igor Bondarenko, Seock-Ah Im, Norikazu Masuda, Marco Colleoni, Angela DeMichele, Sherene Loi, Sunil Verma, Hiroji Iwata, Nadia Harbeck, Sibylle Loibl, Fabrice André, Kathy Puyana Theall, Xin Huang, Carla Giorgetti, Cynthia Huang Bartlett, Massimo Cristofanilli, Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer The New England Journal of Medicine. ,vol. 379, pp. 1926- 1936 ,(2018) , 10.1056/NEJMOA1810527

Michael Lux, Naiba Nabieva, Andreas Hartkopf, Jens Huober, Bernhard Volz, Florin-Andrei Taran, Friedrich Overkamp, Hans-Christian Kolberg, Peyman Hadji, Hans Tesch, Lothar Häberle, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Matthias Beckmann, Erik Belleville, Pauline Wimberger, Carsten Hielscher, Matthias Geberth, Wolfgang Abenhardt, Christian Kurbacher, Rachel Wuerstlein, Christoph Thomssen, Michael Untch, Peter Fasching, Wolfgang Janni, Tanja Fehm, Diethelm Wallwiener, Andreas Schneeweiss, Sara Brucker, Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry Cancers. ,vol. 11, pp. 10- ,(2018) , 10.3390/CANCERS11010010

Stephen Johnston, Miguel Martin, Angelo Di Leo, Seock-Ah Im, Ahmad Awada, Tammy Forrester, Martin Frenzel, Molly C. Hardebeck, Joanne Cox, Susana Barriga, Masakazu Toi, Hiroji Iwata, Matthew P. Goetz, MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer. NPJ breast cancer. ,vol. 5, pp. 5- ,(2019) , 10.1038/S41523-018-0097-Z

Tim Whelan, Don Berry, Gloria Broadwater, Constance Cirrincione, Hyman Muss, Raymond Weiss, Yi Shan, Yong Fu Shao, Xiang Wang, Binghe Xu, Dong-Bing Zhao, Harry Bartelink, Nina Bijker, Jan Bogaerts, Fatima Cardoso, Tanja Cufer, Jean-Pierre Julien, Philip Poortmans, Emiel Rutgers, Cornelis van de Velde, Eva Carrasco, Miguel Angel Segui, Jens Uwe Blohmer, Serban Costa, Bernd Gerber, Christian Jackisch, Gunter von Minckwitz, Mario Giuliano, Michele De Laurentiis, Christina Bamia, Georgia-Angeliki Koliou, Dimitris Mavroudis, Roger A'Hern, Paul Ellis, Lucy Kilburn, James Morden, John Yarnold, Mohammad Sadoon, Augustinus H Tulusan, Stewart Anderson, Gordon Bass, Joe Costantino, James Dignam, Bernard Fisher, Charles Geyer, Eleftherios P Mamounas, Soon Paik, Carol Redmond, D Lawrence Wickerham, Marco Venturini, Claudia Bighin, Simona Pastorino, Paolo Pronzato, Mario Roberto Sertoli, Theodorus Foukakis, Kathy Albain, Rodrigo Arriagada, Elizabeth Bergsten Nordström, Francesco Boccardo, Etienne Brain, Lisa Carey, Alan Coates, Robert Coleman, Candace Correa, Jack Cuzick, Nancy Davidson, Mitch Dowsett, Marianne Ewertz, John Forbes, Richard Gelber, Aron Goldhirsch, Pamela Goodwin, Daniel Hayes, Catherine Hill, James Ingle, Reshma Jagsi, Wolfgang Janni, Hirofumi Mukai, Yasuo Ohashi, Lori Pierce, Vinod Raina, Peter Ravdin, Daniel Rea, Meredith Regan, John Robertson, Joseph Sparano, Andrew Tutt, Giuseppe Viale, Nicholas Wilcken, Norman Wolmark, Wiliam Wood, Milvia Zambetti, Richard Gray, Rosie Bradley, Jeremy Braybrooke, Zulian Liu, Richard Peto, Lucy Davies, David Dodwell, Paul McGale, Hongchao Pan, Carolyn Taylor, William Barlow, Judith Bliss, Paolo Bruzzi, David Cameron, George Fountzilas, Sibylle Loibl, John Mackey, Miguel Martin, Lucia Del Mastro, Volker Möbus, Valentina Nekljudova, Sabino De Placido, Sandra Swain, Michael Untch, Kathleen I Pritchard, Jonas Bergh, Larry Norton, Clare Boddington, Julie Burrett, Mike Clarke, Christina Davies, Fran Duane, Vaughan Evans, Lucy Gettins, Jon Godwin, Robert Hills, Sam James, Hui Liu, Elizabeth MacKinnon, Gurdeep Mannu, Theresa McHugh, Philip Morris, Simon Read, Yaochen Wang, Zhe Wang, Peter Fasching, Nadia Harbeck, Pascal Piedbois, Michael Gnant, Guenther Steger, Angelo Di Leo, Stella Dolci, Prue Francis, Denis Larsimont, Jean Marie Nogaret, Catherine Philippson, Martine Piccart, Sabine Linn, Petronella Peer, Vivianne Tjan-Heijnen, Sonja Vliek, John Mackey, Dennis Slamon, John Bartlett, Vivien H Bramwell, Bingshu Chen, Stephen Chia, Karen Gelmon, Paul Goss, Mark Levine, Wendy Parulekar, Joseph Pater, Eileen Rakovitch, Lois Shepherd, Dongsheng Tu, Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials The Lancet. ,vol. 393, pp. 1440- 1452 ,(2019) , 10.1016/S0140-6736(18)33137-4

David Pérol, Mathieu Robain, Patrick Arveux, Simone Mathoulin-Pélissier, Emmanuel Chamorey, Bernard Asselain, Delphine Berchery, Sophie Gourgou, Mathias Breton, Stéphanie Delaine-Clisant, Muriel Mons, Véronique Diéras, Matthieu Carton, Anne-Valérie Guizard, Lilian Laborde, Carine Laurent, Agnès Loeb, Marie-Ange Mouret-Reynier, Damien Parent, Geneviève Perrocheau, Loïc Campion, Michel Velten, Christian Cailliot, Monia Ezzalfani, Gaëtane Simon, The ongoing French metastatic breast cancer (MBC) cohort: the example-based methodology of the Epidemiological Strategy and Medical Economics (ESME). BMJ Open. ,vol. 9, ,(2019) , 10.1136/BMJOPEN-2018-023568

M.K. Fink, Does adjuvant therapy reduce postmetastatic survival? Annals of Oncology. ,vol. 30, pp. 1184- 1188 ,(2019) , 10.1093/ANNONC/MDZ159

William Jacot, Pierre‐Etienne Heudel, Julien Fraisse, Sophie Gourgou, Séverine Guiu, Florence Dalenc, Barbara Pistilli, Mario Campone, Christelle Levy, Marc Debled, Marianne Leheurteur, Marie Chaix, Claudia Lefeuvre, Anthony Goncalves, Lionel Uwer, Jean‐Marc Ferrero, Jean‐Christophe Eymard, Thierry Petit, Marie‐Ange Mouret‐Reynier, Coralie Courtinard, Paul Cottu, Mathieu Robain, Audrey Mailliez, Real-life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program. International Journal of Cancer. ,vol. 145, pp. 3359- 3369 ,(2019) , 10.1002/IJC.32402

Seock-Ah Im, Yen-Shen Lu, Aditya Bardia, Nadia Harbeck, Marco Colleoni, Fabio Franke, Louis Chow, Joohyuk Sohn, Keun-Seok Lee, Saul Campos-Gomez, Rafael Villanueva-Vazquez, Kyung-Hae Jung, Arunava Chakravartty, Gareth Hughes, Ioannis Gounaris, Karen Rodriguez-Lorenc, Tetiana Taran, Sara Hurvitz, Debu Tripathy, Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer The New England Journal of Medicine. ,vol. 381, pp. 307- 316 ,(2019) , 10.1056/NEJMOA1903765